Arsenite-enhanced procoagulant activity through phosphatidylserine exposure in platelets

Chemical Research in Toxicology

Volumn 20, Issue 12, 2007, Pages 1760-1768

  Bae, Ok Nam ^a   Lim, Kyung Min ^a,e   Noh, Ji Yoon ^a   Chung, Seung Min ^a   Kim, Heon ^b   Lee, Choong Ryeol ^c   Park, Jung Duck ^d   Chung, Jin Ho ^a  

^a Seoul National University   (South Korea)

^b Chungbuk National University College of Medicine   (South Korea)

^c Ulsan University College of Medicine   (South Korea)

^d Chung Ang University   (South Korea)

^e AmorePacific Corporation   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; PHOSPHATIDYLSERINE; PROCOAGULANT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD CLOTTING; CALCIUM METABOLISM; CARDIOVASCULAR DISEASE; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENVIRONMENTAL EXPLOITATION; ENZYME INHIBITION; FLOW CYTOMETRY; FLUID INTAKE; GEL ELECTROPHORESIS; LONG TERM EXPOSURE; MALE; NONHUMAN; RAT; THROMBOCYTE MEMBRANE; THROMBOGENESIS; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; ANIMALS; ARSENITES; BLOOD COAGULATION; BLOOD PLATELETS; CALCIUM; HUMANS; MALE; PHOSPHATIDYLSERINES; PLATELET ACTIVATION; RATS; RATS, SPRAGUE-DAWLEY; THROMBIN; VENOUS THROMBOSIS; WATER POLLUTANTS, CHEMICAL;

RATTUS; RODENTIA;

EID: 38149043620     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx700159y     Document Type: Article

References (55)

1. Abernathy, C. O., Thomas, D. J., and Calderon, R. L. (2003) Health effects and risk assessment of arsenic. J. Nutr. 133, 1536S-1538S.
2. Mead, M. N. (2005) Arsenic: in search of an antidote to a global poison. Environ. Health Perspect. 113, A378-A386.
3. Yoshida, T., Yamauchi, H., and Fan Sun, G. (2004) Chronic health effects in people exposed to arsenic via the drinking water: dose-response relationships in review. Toxicol. Appl. Pharmacol. 198, 243-252.
4. Chen, C. J., Chiou, H. Y., Chiang, M. H., Lin, L. J., and Tai, T. Y. (1996) Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arterioscler., Thromb., Vasc. Biol. 16, 504-510.
5. Wu, M. M., Kuo, T. L., Hwang, Y. H., and Chen, C. J. (1989) Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am. J. Epidemiol. 130, 1123-1132.
6. Chiou, J. M., Wang, S. L., Chen, C. J., Deng, C. R., Lin, W., and Tai, T. Y. (2005) Arsenic ingestion and increased microvascular disease risk: observations from the south-western arseniasis-endemic area in Taiwan. Int. J. Epidemiol. 34, 936-943.
7. Navas-Acien, A., Sharrett, A. R., Silbergeld, E. K., Schwartz, B. S., Nachman, K. E., Burke, T. A., and Guallar, E. (2005) Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am. J. Epidemiol. 162, 1037-1049.
8. Simeonova, P. P., and Luster, M. I. (2004) Arsenic and atherosclerosis. Toxicol. Appl. Pharmacol. 198, 444-449.
9. Tseng, C. H. (2002) An overview on peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Angiology 53, 529-537.
10. Kumagai, Y., and Pi, J. (2004) Molecular basis for arsenic-induced alteration in nitric oxide production and oxidative stress: implication of endothelial dysfunction. Toxicol. Appl. Pharmacol. 198, 450-457.
11. Kao, Y. H., Yu, C. L., Chang, L. W., and Yu, H. S. (2003) Low concentrations of arsenic induce vascular endothelial growth factor and nitric oxide release and stimulate angiogenesis in vitro. Chem. Res. Toxicol. 16, 460-468.
12. Lee, M. Y., Bae, O. N., Chung, S. M., Kang, K. T., Lee, J. Y., and Chung, J. H. (2002) Enhancement of platelet aggregation and thrombus formation by arsenic in drinking water: a contributing factor to cardiovascular disease. Toxicol. Appl. Pharmacol. 179, 83-88.
13. Lee, M. Y., Lee, Y. H., Lim, K. M., Chung, S. M., Bae, O. N., Kim, H., Lee, C. R., Park, J. D., and Chung, J. H. (2005) Inorganic arsenite potentiates vasoconstriction through calcium sensitization in vascular smooth muscle. Environ. Health Perspect. 113, 1330-1335.
14. Gawaz, M. (2004) Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium. Cardiovasc. Res. 61, 498-511.
15. Ruggeri, Z. M. (2002) Platelets in atherothrombosis. Nat. Med. 8, 1227-1234.
16. Heemskerk, J. W., Bevers, E. M., and Lindhout, T. (2002) Platelet activation and blood coagulation. Thromb. Haemostasis 88, 186-193.
17. Bevers, E. M., Comfurius, P., and Zwaal, R. F. (1993) Mechanisms involved in platelet procoagulant response. Adv. Exp. Med. Biol. 344, 195-207.
18. Preston, R. A., Jy, W., Jimenez, J. J., Mauro, L. M., Horstman, L. L., Valle, M., Aime, G., and Ahn, Y. S. (2003) Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 41, 211-217.
19. Solum, N. O. (1999) Procoagulant expression in platelets and defects leading to clinical disorders. Arterioscler., Thromb., Vasc. Biol. 19, 2841-2846.
20. Aoki, I., Aoki, N., Kawano, K., Shimoyama, K., Maki, A., Homori, M., Yanagisawa, A., Yamamoto, M., Kawai, Y., and Ishikawa, K. (1997) Platelet-dependent thrombin generation in patients with hyperlipidemia. J. Am. Coll. Cardiol. 30, 91-96.
21. Bonomini, M., Dottori, S., Amoroso, L., Arduini, A., and Sirolli, V. (2004) Increased platelet phosphatidylserine exposure and caspase activation in chronic uremia. J. Thromb. Haemostasis 2, 1275-1281.
22. Lentz, B. R. (2003) Exposure of platelet membrane phosphatidylserine regulates blood coagulation. Prog. Lipid Res. 42, 423-438.
23. Daleke, D. L., and Lyles, J. V. (2000) Identification and purification of aminophospholipid flippases. Biochim. Biophys. Acta 1486, 108-127.
24. Fox, J. E., Austin, C. D., Reynolds, C. C., and Steffen, P. K. (1991) Evidence that agonist-induced activation of calpain causes the shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets. J. Biol. Chem. 266, 13289-13295.
25. Zwaal, R. F., Comfurius, P., and Bevers, E. M. (2005) Surface exposure of phosphatidylserine in pathological cells. Cell. Mol. Life Sci. 62, 971-988.
26. Martinez, M. C., Tesse, A., Zobairi, F., and Andriantsitohaina, R. (2005) Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am. J. Physiol. 288, H1004-H1009.
27. Morel, O., Toti, F., Hugel, B., and Freyssinet, J. M. (2004) Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr. Opin. Hematol. 11, 156-164.
28. Heemskerk, J. W., Willems, G. M., Rook, M. B., and Sage, S. O. (2001) Ragged spiking of free calcium in ADP-stimulated human platelets: regulation of puff-like calcium signals in vitro and ex vivo. J. Physiol. 535, 625-635.
29. Smeets, E. F., Heemskerk, J. W., Comfurius, P., Bevers, E. M., and Zwaal, R. F. (1993) Thapsigargin amplifies the platelet procoagulant response caused by thrombin. Thromb. Haemostasis 70, 1024-1029.
30. Williamson, P., Bevers, E. M., Smeets, E. F., Comfurius, P., Schlegel, R. A., and Zwaal, R. F. (1995) Continuous analysis of the mechanism of activated transbilayer lipid movement in platelets. Biochemistry 34, 10448-10455.
31. Shin, J. H., Lim, K. M., Noh, J. Y., Bae, O. N., Chung, S. M., Lee, M. Y., and Chung, J. H. (2007) Lead-induced procoagulant activation of erythrocytes through phosphatidylserine exposure may lead to thrombotic diseases. Chem. Res. Toxicol. 20, 38-43.
32. Horstman, L. L., and Ann, Y. S. (1999) Platelet microparticles: a wide-angle perspective. Crit. Rev. Oncol. Hematol. 30, 111-142.
33. Pasquet, J. M., Dachary-Prigent, J., and Nurden, A. T. (1996) Calcium influx is a determining factor of calpain activation and microparticle formation in platelets. Eur. J. Biochem. 239, 647-654.
34. Bevers, E. M., Comfurius, P., Dekkers, D. W., and Zwaal, R. F. (1999) Lipid translocation across the plasma membrane of mammalian cells. Biochim. Biophys. Acta 1439, 317-330.
35. Herbert, J. M., Bernat, A., and Maffrand, J. P. (1992) Importance of platelets in experimental venous thrombosis in the rat. Blood 80, 2281-2286.
36. Berg, M., Tran, H. C., Nguyen, T. C., Pham, H. V., Schertenleib, R., and Giger, W. (2001) Arsenic contamination of groundwater and drinking water in Vietnam: a human health threat. Environ. Sci. Technol. 35, 2621-2626.
37. Bhattacharyya, R., Chatterjee, D., Nath, B., Jana, J., Jacks, G., and Vahter, M. (2003) High arsenic groundwater: mobilization, metabolism and mitigation - an overview in the Bengal Delta Plain. Mol. Cell. Biochem. 253, 347-355.
38. Xia, Y., and Liu, J. (2004) An overview on chronic arsenism via drinking water in PR China. Toxicology 198, 25-29.
39. Heydorn, K. (1970) Environmental variation of arsenic levels in human blood determined by neutron activation analysis. Clin. Chim. Acta 28, 349-357.
40. Pi, J., Kumagai, Y., Sun, G., Yamauchi, H., Yoshida, T., Iso, H., Endo, A., Yu, L., Yuki, K., Miyauchi, T., and Shimojo, N. (2000) Decreased serum concentrations of nitric oxide metabolites among Chinese in an endemic area of chronic arsenic poisoning in inner Mongolia. Free Radical Biol. Med. 28, 1137-1142.
41. Augereau, O., Rossignol, R., DeGiorgi, F., Mazat, J. P., Letellier, T., and Dachary-Prigent, J. (2004) Apoptotic-like mitochondrial events associated to phosphatidylserine exposure in blood platelets induced by local anaesthetics. Thromb. Haemostasis 92, 104-113.
42. 2+-ATPase inhibitors. Biochemistry 34, 11625-11634.
43. Kumar, R., Beguin, S., and Hemker, H. C. (1994) The influence of fibrinogen and fibrin on thrombin generation - evidence for feedback activation of the clotting system by clot bound thrombin. Thromb. Haemostasis 72, 713-721.
44. Jiang, S. J., Lin, T. M., Wu, H. L., Han, H. S., and Shi, G. Y. (2002) Decrease of fibrinolytic activity in human endothelial cells by arsenite. Thromb. Res. 105, 55-62.
45. Shen, M. C., Tseng, W. P., and Chen, C. S. (1983) Increased circulating platelet aggregates and coagulation factors in patients with Blackfoot disease. Taiwan Yixuehui Zazhi 82, 816-821.
46. Wu, H. L., Yang, W. H., Wang, M. Y., and Shi, G. Y. (1993) Impaired fibrinolysis in patients with Blackfoot disease. Thromb. Res. 72, 211-218.
47. Mallat, Z., Benamer, H., Hugel, B., Benessiano, J., Steg, P. G., Freyssinet, J. M., and Tedgui, A. (2000) Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 101, 841-843.
48. Vidal, C., Spaulding, C., Picard, F., Schaison, F., Melle, J., Weber, S., and Fontenay-Roupie, M. (2001) Flow cytometry detection of platelet procoagulation activity and microparticles in patients with unstable angina treated by percutaneous coronary angioplasty and stent implantation. Thromb. Haemostasis 86, 784-790.
49. Ault, K. A. (2001) The clinical utility of flow cytometry in the study of platelets. Semin. Hematol. 38, 160-168.
50. Morel, O., Toti, F., Hugel, B., Bakouboula, B., Camoin-Jau, L., Dignat-George, F., and Freyssinet, J. M. (2006) Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler., Thromb., Vasc. Biol. 26, 2594-2604.
51. Andrews, R. K., and Berndt, M. C. (2004) Platelet physiology and thrombosis. Thromb. Res. 114, 447-453.
52. Florea, A. M., Yamoah, E. N., and Dopp, E. (2005) Intracellular calcium disturbances induced by arsenic and its methylated derivatives in relation to genomic damage and apoptosis induction. Environ. Health Perspect. 113, 659-664.
53. 2+ pumping ATPase by vitamin C. Biosci. Rep. 19, 11-15.
54. 2+ store. J. Biol. Chem. 269, 17550-17555.
55. Sorimachi, H., Ishiura, S., and Suzuki, K. (1997) Structure and physiological function of calpains. Biochem. J. 328, 721-732.